AAAAAA

   
Results: 1-17 |
Results: 17
BIOELECTRICAL-IMPEDANCE ANALYSIS PREDICTS OUTCOME IN PATIENTS WITH SUSPECTED BACTEREMIA
Authors: SCHWENK A WARD LC ELIA M SCOTT GM
Citation: A. Schwenk et al., BIOELECTRICAL-IMPEDANCE ANALYSIS PREDICTS OUTCOME IN PATIENTS WITH SUSPECTED BACTEREMIA, Infection, 26(5), 1998, pp. 277-282
GENERATION AND IMMORTALIZATION OF A TUMOR-SPECIFIC CYTOTOXIC T-CELL LINE FROM A HEALTHY DONOR
Authors: PECHER G SCHWENK A ZIEGNER M KILGER E HAMMERSCHMIDT W
Citation: G. Pecher et al., GENERATION AND IMMORTALIZATION OF A TUMOR-SPECIFIC CYTOTOXIC T-CELL LINE FROM A HEALTHY DONOR, European journal of cancer, 33, 1997, pp. 61-61
LIPOSOME-MEDIATED GENE-TRANSFER INTO HUMAN DENDRITIC CELLS
Authors: PECHER G SPAHN G ZIEGNER M SCHWENK A DORKEN B
Citation: G. Pecher et al., LIPOSOME-MEDIATED GENE-TRANSFER INTO HUMAN DENDRITIC CELLS, European journal of cancer, 33, 1997, pp. 62-62
VIRUS-FREE B-CELL LINES EXPRESSING MUCIN (MUC1) GENE BY TRANSFECTION WITH A MINI-EBV PLASMID
Authors: KILGER E PECHER G SCHWENK A HAMMERSCHMIDT W
Citation: E. Kilger et al., VIRUS-FREE B-CELL LINES EXPRESSING MUCIN (MUC1) GENE BY TRANSFECTION WITH A MINI-EBV PLASMID, European journal of cancer, 33, 1997, pp. 126-126
VIROLOGICAL TREATMENT FAILURE OF PROTEASE INHIBITOR THERAPY IN AN UNSELECTED COHORT OF HIV-INFECTED PATIENTS
Authors: FATKENHEUER G THEISEN A ROCKSTROH J GRABOW T WICKE C BECKER K WIELAND U PFISTER H REISER M HEGENER P FRANZEN C SCHWENK A SALZBERGER B
Citation: G. Fatkenheuer et al., VIROLOGICAL TREATMENT FAILURE OF PROTEASE INHIBITOR THERAPY IN AN UNSELECTED COHORT OF HIV-INFECTED PATIENTS, AIDS, 11(14), 1997, pp. 113-116
CMV-ANTIGENEMIA IN PERIPHERAL-BLOOD FOR THE DIAGNOSIS OF CMV DISEASE IN HIV-INFECTED PATIENTS
Authors: SALZBERGER B FRANZEN C FATKENHEUER G CORNELY O SCHWENK A RASOKAT H DIEHL V SCHRAPPE M
Citation: B. Salzberger et al., CMV-ANTIGENEMIA IN PERIPHERAL-BLOOD FOR THE DIAGNOSIS OF CMV DISEASE IN HIV-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 11(4), 1996, pp. 365-369
RESTING ENERGY-EXPENDITURE, WEIGHT-LOSS, AND ALTERED BODY-COMPOSITIONIN HIV-INFECTION
Authors: SCHWENK A HOFFERBELITZ E JUNG B KREMER G BURGER B SALZBERGER B DIEHL V SCHRAPPE M
Citation: A. Schwenk et al., RESTING ENERGY-EXPENDITURE, WEIGHT-LOSS, AND ALTERED BODY-COMPOSITIONIN HIV-INFECTION, Nutrition, 12(9), 1996, pp. 595-601
NUTRITION AND HIV-INFECTION .2. DIETETIC TREATMENT
Authors: SUTTMANN U SCHWENK A
Citation: U. Suttmann et A. Schwenk, NUTRITION AND HIV-INFECTION .2. DIETETIC TREATMENT, Medizinische Klinik, 91(8), 1996, pp. 521-525
NUTRITION AND HIV-INFECTION .1. CAUSES AN D SEQUELAE OF MALNUTRITION
Authors: SCHWENK A SUTTMANN U
Citation: A. Schwenk et U. Suttmann, NUTRITION AND HIV-INFECTION .1. CAUSES AN D SEQUELAE OF MALNUTRITION, Medizinische Klinik, 91(7), 1996, pp. 466-471
IMMUNOLOGICALLY CONFIRMED DISSEMINATED, ASYMPTOMATIC ENCEPHALITOZOON-CUNICULI INFECTION OF THE GASTROINTESTINAL-TRACT IN A PATIENT WITH AIDS
Authors: FRANZEN C SCHWARTZ DA VISVESVARA GS MULLER A SCHWENK A SALZBERGER B FATKENHEUER G HARTMANN P MAHRLE G DIEHL V SCHRAPPE M
Citation: C. Franzen et al., IMMUNOLOGICALLY CONFIRMED DISSEMINATED, ASYMPTOMATIC ENCEPHALITOZOON-CUNICULI INFECTION OF THE GASTROINTESTINAL-TRACT IN A PATIENT WITH AIDS, Clinical infectious diseases, 21(6), 1995, pp. 1480-1484
INTESTINAL MICROSPORIDIOSIS WITH SEPTATA-INTESTINALIS IN A PATIENT WITH AIDS - RESPONSE TO ALBENDAZOLE
Authors: FRANZEN C MULLER A SCHWENK A SALZBERGER B FATKENHEUER G MAHRLE G DIEHL V SCHRAPPE M
Citation: C. Franzen et al., INTESTINAL MICROSPORIDIOSIS WITH SEPTATA-INTESTINALIS IN A PATIENT WITH AIDS - RESPONSE TO ALBENDAZOLE, The Journal of infection, 31(3), 1995, pp. 237-239
NASOENTERAL NUTRITION FOR HIV-ASSOCIATED WASTING - PROMISE AND OUTCOME
Authors: SCHULTEBOCKHOLT A SCHWENK A FRIEDEL A SCHRAPPE M LEMBCKE B
Citation: A. Schultebockholt et al., NASOENTERAL NUTRITION FOR HIV-ASSOCIATED WASTING - PROMISE AND OUTCOME, Gastroenterology, 108(4), 1995, pp. 752-752
ORAL SUPPLEMENTS IN HIV-INFECTED PATIENTS WITH CHRONIC WASTING - A PROSPECTIVE TRIAL
Authors: BURGER B SCHWENK A JUNGER H OLLENSCHLAGER G WESSEL D DIEHL V SCHRAPPE M
Citation: B. Burger et al., ORAL SUPPLEMENTS IN HIV-INFECTED PATIENTS WITH CHRONIC WASTING - A PROSPECTIVE TRIAL, Medizinische Klinik, 89(11), 1994, pp. 579-581
FOSCARNET AND GANCICLOVIR COMBINATION THERAPY FOR CMV DISEASE IN HIV-INFECTED PATIENTS
Authors: SALZBERGER B STOEHR A HEISE W FATKENHEUER G SCHWENK A FRANZEN C CORNELY O SCHRAPPE M
Citation: B. Salzberger et al., FOSCARNET AND GANCICLOVIR COMBINATION THERAPY FOR CMV DISEASE IN HIV-INFECTED PATIENTS, Infection, 22(3), 1994, pp. 197-200
EVALUATION OF NUTRITIONAL COUNSELING IN HIV-ASSOCIATED MALNUTRITION
Authors: SCHWENK A BURGER B OLLENSCHLAGER G STUTZER H WESSEL D DIEHL V SCHRAPPE M
Citation: A. Schwenk et al., EVALUATION OF NUTRITIONAL COUNSELING IN HIV-ASSOCIATED MALNUTRITION, Clinical nutrition, 13(4), 1994, pp. 212-220
NUTRITION BEHAVIOR OF MALNOURISHED HIV-INFECTED PATIENTS AND INTENSIFIED ORAL NUTRITIONAL INTERVENTION
Authors: BURGER B OLLENSCHLAGER G SCHRAPPE M STUTE A FISCHER M WESSEL D SCHWENK A DIEHL V
Citation: B. Burger et al., NUTRITION BEHAVIOR OF MALNOURISHED HIV-INFECTED PATIENTS AND INTENSIFIED ORAL NUTRITIONAL INTERVENTION, Nutrition, 9(1), 1993, pp. 43-44
CLINICAL RISK-FACTORS FOR MALNUTRITION IN HIV-1-INFECTED PATIENTS
Authors: SCHWENK A BURGER B WESSEL D STUTZER H ZIEGENHAGEN D DIEHL V SCHRAPPE M
Citation: A. Schwenk et al., CLINICAL RISK-FACTORS FOR MALNUTRITION IN HIV-1-INFECTED PATIENTS, AIDS, 7(9), 1993, pp. 1213-1219
Risultati: 1-17 |